Starling Oncology (STLN) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 17, 2026, to be held virtually for stockholders of record as of April 24, 2026.

• Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request.

Voting matters and shareholder proposals

• Election of eight directors is up for vote.

• Ratification of BDO as the independent registered public accounting firm for 2026.

• Advisory vote on executive compensation (say-on-pay) is included.

• Advisory vote on the preferred frequency of future say-on-pay votes is proposed, with the board recommending a 1-year frequency.

Board of directors and corporate governance

• Eight nominees for director positions are listed: Brad Hively, Karen Johnson, Mohit Kaushal, Anne McGeorge, Mark Pacala, Mark Stolper, Kimberly Tzoumakas, and Daniel Virnich.